[1]王力普,翟付平,马 伟,等.蒲苓连夏方治疗难治性反流性食管炎临床观察[J].陕西中医,2021,(11):1557-1560.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.014]
　WANG Lipu,ZHAI Fuping,MA Wei,et al.Clinical observation of Puling Lianxia decoction in the treatment of refractory reflux esophagitis[J].,2021,(11):1557-1560.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.014]
点击复制

蒲苓连夏方治疗难治性反流性食管炎临床观察

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年11期
页码:
1557-1560
栏目:
临床研究
出版日期:
2021-11-05

文章信息/Info

Title:
Clinical observation of Puling Lianxia decoction in the treatment of refractory reflux esophagitis
作者:
王力普1; 翟付平1; 马 伟1; 白海燕2; 李维康1; 刘凯娟1; 李春蕾1; 杨 倩2
(1.河北中医学院研究生院,河北 石家庄 050091; 2.河北中医学院第一附属医院,河北 石家庄 050000)
Author(s):
WANG Lipu; ZHAI Fuping; MA Wei; BAI Haiyan; LI Weikang; LIU Kaijuan; LI Chunlei; YANG Qian
(Graduate School of Hebei University of Traditional Chinese Medicine,Shijiazhuang 050091,China)
关键词:
难治性反流性食管炎;  蒲苓连夏方;  雷贝拉唑钠肠溶胶囊;  枸橼酸莫沙必利片;  24 h食管pH监测
Keywords:
Refractory reflux esophagitis;  Puling Lianxia decoction;  Rabeprazole sodium enteric-coated capsules;  Mosapride citrate tablet;  24-hour esophageal pH monitoring
分类号:
R 571
DOI:
DOI:10.3969/j.issn.1000-7369.2020.11.014
文献标志码:
A
摘要:
目的:研究蒲苓连夏方治疗难治性反流性食管炎的临床观察。方法:选取60例难治性反流性食管炎病例,按照随机数字表法,分为观察组(予蒲苓连夏方)和对照组(予雷贝拉唑钠肠溶胶囊和枸橼酸莫沙必利片),每组30例,疗程均为8周。治疗结束后分析两组治疗前后的中医证候疗效、24 h食管pH监测、胃镜下食管黏膜积分、中医证候积分结果、胃蛋白酶浓度,治疗结束随访3个月,观察两组的复发率。结果:观察组总有效率比对照组高(P<0.05); 两组患者治疗后pH<4总时间百分比差异无统计学意义(P>0.05),两组患者的反流持续≥5 min次数、最长反流持续时间、De Meester得分均降低(P<0.05),且观察组低于对照组(P<0.05); 两组治疗后胃镜下食管黏膜积分、中医证候积分、胃蛋白酶浓度均降低(P<0.05),且观察组低于对照组(P<0.05); 观察组复发率较对照组低(P<0.05)。结论:蒲苓连夏方有效率高,且复发率低,临床疗效确切。
Abstract:
Objective:To study the clinical observation of Puling Lianxia decoction in the treatment of refractory reflux esophagitis.Methods:60 cases of refractory reflux esophagitis were randomly divided into observation group(treated with Puling Lianxia decoction)and control group(treated with rabeprazole sodium enteric-coated capsules and mosapride citrate tablet),30 cases in each group,and the course of treatment was 8 weeks.After treatment,the TCM syndrome efficacy,24-hour esophageal pH monitoring,endoscopic esophageal mucosal score,TCM syndrome score and pepsin concentration of the two groups before and after treatment were analyzed.After treatment,the patients were followed up for 3 months to observe the recurrence rate of the two groups.Results:The total effective rate of the observation group was higher than that of the control group(P<0.05).There was no significant difference in the total time percentage of pH<4 between the two groups after treatment(P>0.05).The number of reflux lasting ≥5 min,the longest reflux duration and De Meester scoring of the two groups were decreased(P<0.05),and the observation group was lower than the control group(P<0.05).After treatment,the scores of esophageal mucosa,TCM syndrome score and pepsin concentration in the observation group were lower than those in the control group(P<0.05).The recurrence rate of the observation group was lower than that of the control group(P<0.05).Conclusion:The effective rate of Puling Lianxia decoction is high,and the recurrence rate is low.

参考文献/References:

[1] 李芳芳,黄巨霞.雷贝拉唑联合莫沙必利对反流性食管炎患者幽门螺杆菌感染及炎症因子水平影响研究[J].陕西医学杂志,2019,48(10):1378-1380.
[2] 李 丹,顾志坚.半夏泻心汤治疗胃食管反流病疗效观察[J].陕西中医,2017,38(7):903-904.
[3] 李军祥,陈 誩,李 岩.胃食管反流病中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(3):221-226.
[4] 中华医学会消化病学分会.2014年中国胃食管反流病专家共识意见[J].胃肠病学,2015,20(3):155-168.
[5] 周英武,张玉禄.疏肝胃安颗粒联合埃索美拉唑镁肠溶片和莫沙必利片治疗胃食管反流病56例临床观察[J].中医杂志,2019,60(13):1118-1122.
[6] 国家食品药品监督管理总局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:366-367.
[7] Pilone V,Tramontano S,Renzulli M,et al.Gastroesophageal reflux after sleeve gastrectomy:New onset and effect on symptoms on a prospective evaluation[J].Obes Surg,2019,29(11):3638-3645.
[8] 邱德凯,马 雄,李治平.难治性消化系统疾病[M].上海:上海科学技术出版社,2007:1-13.
[9] 丁 瑜,肖 璐,张译文,等.胃食管反流患者唾液中胃蛋白酶与胃蛋白酶原关系分析[J].中国急救复苏与灾害医学杂志,2020,15(8):951-953.
[10] 汤进芝,王 雯.胃食管反流病中食管pH检测进展[J].国际消化病杂志,2014,34(3):157-160.
[11] 陆维宏,程胜平,周水英,等.中西医结合治疗非糜烂性胃食管反流病临床观察[J].中国中医药信息杂志,2011,18(6):69-70.
[12] 李吉梅.埃索美拉唑治疗反流性食管炎75例临床观察[J].陕西医学杂志,2017,46(9):1286-1288.
[13] 袁耀宗,侯晓华,邹多武,等.胃食管反流病治疗共识意见(2007?西安)[J].现代消化及介入诊疗,2008,13(1):71-72.
[14] 孙金山,聂占国.胃食管反流病内镜治疗进展[J].中国微创外科杂志,2018,18(5):454-456.
[15] 王三强,许敏光,魏会珍,等.反流性食管炎中医学研究进展[J].陕西中医,2020,41(2):266-268.
[16] 屈亚威,王伟岸,张 晓,等.精神心理因素与难治性胃食管反流病发病关系的研究[J].胃肠病学和肝病学杂志,2015,24(12):1445-1447.
[17] 邰 佳,邹俊波,史亚军,等.GC-MS分析水蒸气蒸馏法提取石菖蒲挥发油过程中油水分配规律[J].中草药,2020,51(1):59-66.
[18] 张明发,沈雅琴.半夏提取物对呼吸和消化系统药理作用的研究进展[J].抗感染药学,2017,14(8):1457-1462.
[19] 杨翠荣.郁金药理及中医临床应用略述[J].光明中医,2014,29(8):1772-1773.
[20] 黄 潇,刘 婧,吴建华,等.基于灰色关联法分析栀子提取物抗炎作用谱效关系[J].中成药,2020,42(1):233-237.

相似文献/References:

[1]刘凯娟,李维康,王力普,等.李佃贵从“五脏”论治难治性反流性食管炎经验*[J].陕西中医,2020,(8):1144.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]
　LIU Kaijuan,LI Weikang,WANG Lipu,et al.Traditional Chinese medicine master Li Diangui's experience in treating refractory reflux esophagitis from “five organs”[J].,2020,(11):1144.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.035]

备注/Memo

备注/Memo:
基金项目:国家科技部重点研发课题(2018YFC1704100); 河北省中医药管理局科研计划项目(2019017)
更新日期/Last Update: 2021-11-10